Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients
Authors
Keywords
-
Journal
BIOCHEMICAL GENETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-19
DOI
10.1007/s10528-022-10199-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The association of single nucleotide polymorphisms (SNPs) with breast density and breast cancer survival: the Malmö Diet and Cancer Study
- (2020) Hanna Sartor et al. ACTA RADIOLOGICA
- 70P Genetic polymorphisms of ESR1 are associated with hormone resistance to aromatase inhibitors therapy in patients with metastatic luminal breast cancer (MLBC)
- (2020) T. Tarasenko et al. ANNALS OF ONCOLOGY
- ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy
- (2019) Jia Zhong et al. Thoracic Cancer
- Pathways to Endocrine Therapy Resistance in Breast Cancer
- (2019) Md. Moquitul Haque et al. Frontiers in Endocrinology
- The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer
- (2019) Pedro De Marchi et al. ORAL ONCOLOGY
- SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
- (2018) Raffaele Palmirotta et al. Oncotarget
- ESR1 PvuII (rs2234693 T>C) polymorphism and cancer susceptibility: Evidence from 80 studies
- (2018) Xiaoqi Liu et al. Journal of Cancer
- Association of estrogen receptor α PvuII and XbaI polymorphisms with prostate cancer susceptibility and risk stratification: a meta-analysis from case-control studies
- (2017) Yining Zhao et al. OncoTargets and Therapy
- PD-1 rs2227982 Polymorphism Is Associated With the Decreased Risk of Breast Cancer in Northwest Chinese Women
- (2016) Hong-Tao Ren et al. MEDICINE
- Association Between Single Nucleotide Polymorphisms in DNA Polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population
- (2016) Zhi-Jun Dai et al. MEDICINE
- A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer
- (2016) Taishun Li et al. PLoS One
- Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
- (2016) Shabbir Ahmed et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Progress in adjuvant chemotherapy for breast cancer: an overview
- (2015) Jesus Anampa et al. BMC Medicine
- Association Between ESR1 PvuII, XbaI, and P325P Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis
- (2015) Yiming Zhang et al. MEDICAL SCIENCE MONITOR
- Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer
- (2015) Yosuke Hirotsu et al. Molecular Genetics & Genomic Medicine
- Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies
- (2014) Zhenwei Gu et al. TUMOR BIOLOGY
- Genetic polymorphims of estrogen receptor alpha −397 PvuII (T>C) and −351 XbaI (A>G) in a portuguese population: prevalence and relation with breast cancer susceptibility
- (2013) A. C. Ramalhinho et al. MOLECULAR BIOLOGY REPORTS
- Genomics, personalized medicine and cancer practice
- (2012) Janet Dancey CLINICAL BIOCHEMISTRY
- Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial
- (2012) John R Mackey et al. LANCET ONCOLOGY
- Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women
- (2010) Lori C. Sakoda et al. Cancer Epidemiology
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- A review of estrogen receptor α gene (ESR1) polymorphisms, mood, and cognition
- (2010) Erin E. Sundermann et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Genome-wide association study identifies five new breast cancer susceptibility loci
- (2010) Clare Turnbull et al. NATURE GENETICS
- Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis
- (2009) Ni Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
- (2009) Stephen Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer
- (2009) Margot Burnell et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
- (2009) Paul Ellis et al. LANCET
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Concurrent Doxorubicin Plus Docetaxel Is Not More Effective Than Concurrent Doxorubicin Plus Cyclophosphamide in Operable Breast Cancer With 0 to 3 Positive Axillary Nodes: North American Breast Cancer Intergroup Trial E 2197
- (2008) Lori J. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search